Drugdiscovery >> Clinical Trials >> News
4079
Views
Psoriasis Drug Tested Against Diabetes - drugdiscovery.com
Psoriasis Drug Tested Against Diabetes - drugdiscovery.com


Encouraging results from the T1DAL study (Targeting effector memory T-cells with alefacept in new onset type 1 diabetes), led by Mark Rigby from Indiana University and Riley Hospital for Children in Indianapolis and sponsored by the Immune Tolerance Network (ITN) with additional support from JDRF, are published in The Lancet Diabetes & Endocrinology. Alefacept, an engineered fusion protein targeting a surface molecule, CD2, found on T-lymphocytes, was the first biologic therapy approved for moderate to seve
Read More >>


Tags: alefacept, diabetes, psoriasis, treatment, clinical trial - September 23, 2013
Related Articles
4053
Views
Pfizer’s  RA drug Xeljanz effective as a treatment for psoriasis Pfizer’s RA drug Xeljanz effective as a treatment for psoriasis
The results of the first two of five Phase 3 trials of Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib) , a Janus kinase (JAK) inhibitor, indicate that it might be an effective treatment for Read More >>

Tags: Xeljanz,tofacitinib, plaque psoriasis, clinical trial

4026
Views
Psoriasis spray successful in early clinical trials Psoriasis spray successful in early clinical trials
Lipidor announced that its Akvano/calcipotriol spray formulation for the treatment of psoriasis vulgaris showed effective in a phase 1/2a study. Read More >>

Tags: Lipidor, akvano/calcipotriol spray formulation, calcipotriol, spray, treatment, psoriasis, clinical trial

2844
Views
BMS diabetes drug successful in late-stage study BMS diabetes drug successful in late-stage study
Bristol-Myers Squibb has announced that its diabetes drug dapagliflozin, helped improve blood sugar levels and reduce body weight in patients with type 2 diabetes who were taking a combination of metf Read More >>

Tags: type 2 diabetes, Bristol-Myers Squibb, dapagliflozin, clinical trial, Forxiga

2336
Views
Qsymia weight loss drug delays diabetes progression Qsymia weight loss drug delays diabetes progression
A late-stage clinical trial of Vivus’ weight loss drug showed that patients with prediabetes or metabolic syndrome, who were treated with Qsymia, were significantly less likely to develop type 2 d Read More >>

Tags: Qsymia, weight loss, drug, Vivus, type 2 diabetes

3903
Views
Pacritinib to be tested in a late-stage trial as a treatment for myelofibrosis Pacritinib to be tested in a late-stage trial as a treatment for myelofibrosis
Cell Therapeutics announced a late-stage trial of pacritinib as a treatment for a blood disorder called myelofibrosis. Pacritinib will be compared to the best available treatment for myelofibrosis, Ja Read More >>

Tags: Pacritinib, Cell Therapeutics, myelofibrosis, clinical trial, treatment

3080
Views
The new way of finding diabetes during pregnancy The new way of finding diabetes during pregnancy
Traditional ways of testing diabetes during pregnancy are often fail to find this symptom early enough. Thanks to the Clinical Practice Guideline, tests can be more effective, which means, several mor Read More >>

Tags: babies, diabetes, pregnancy, test, clinical practice.

4818
Views
Tresiba efficient in type 2 diabetes patients - study shows Tresiba efficient in type 2 diabetes patients - study shows
The results of the study demonstrate that Novo Nordisk’s recently launched drug Tresiba (insulin degludec) enables patients with type 2 diabetes to sustain good long-term glycemic control, when used Read More >>

Tags: Tresiba, glycemic control, type 2 diabetes, Novo Nordisk, insulin degludec

7078
Views
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial
The data from DUALT 1 trial show that an investigational therapy IDegLira [Tresiba (insulin degludec)/Victoza (liraglutide injection)] achieved statistically significant greater reduction in blood sug Read More >>

Tags: Novo Nordisk, type 2 diabetes, DUALT 1 trial, IDegLira, Tresiba, insulin degludec, Victoza, liraglutide, combination

5891
Views
Trajenta successful  in Phase III trial in elderly Type 2 diabetes patients Trajenta successful in Phase III trial in elderly Type 2 diabetes patients
Trajenta (linagliptin), marketed by Eli Lilly and Boehringer Ingelheim, showed safe and effective in Phase III trial, significantly reducing the blood glucose levels in elderly people with Type 2 diab Read More >>

Tags: Trajenta, type 2 diabetes, elderly, blood glucose control

4686
Views
Teplizumab effective in phase 2 Teplizumab effective in phase 2
Teplizumab is an experimental drug designed to block the advance of type 1 diabetes in its earliest stages. It showed success in phase II clinical trial in patients who still had moderately healthy Read More >>

Tags: Teplizumab,experimental drug, clinical trial, type 1 diabetes, insulin, immunotherapy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013